A Multiple Dose Pharmacokinetic Study of Perampanel in Korean Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2018
Price : $35 *
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Pharmacokinetics
- Sponsors Eisai Co Ltd
- 01 Aug 2018 Results of pooled data from this study and other two studies were, published in the Clinical Pharmacology in Drug Development.
- 19 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Feb 2014 According to ClinicalTrials.gov record, planned end date changed from 1 Apr 2015 to 1 Apr 2014.